Integrated system for 3D tissue culture
Summary
The USPTO granted Patent US12595449B2 to VALO Health, Inc. covering an integrated system with embedded electrodes for growing, maintaining, and using 3D tissues in vitro. The patent includes 13 claims under CPC classifications C12M and C12N covering scalable, automated tissue stimulation devices and systems. The filing date was February 3, 2021, with Application No. 17798048.
What changed
The USPTO issued Patent US12595449B2 to VALO Health, Inc. for an integrated system enabling 3D tissue culture through embedded electrodes. The patent covers devices, apparatuses, and systems for scalable, automated tissue stimulation in vitro. The 8 named inventors include Roozbeh Aschar-Sobbi, Maw-Lin Kuo, Roger Stenerson, Winston Sun, and others. The patent provides intellectual property protection for tissue engineering technology spanning CPC codes in the C12M and C12N classifications.
This patent grant establishes VALO Health's proprietary rights in 3D tissue culture technology and may affect freedom-to-operate considerations for competitors developing similar electrode-based tissue stimulation systems. Companies in the biotechnology, pharmaceutical research, and medical device sectors developing 3D cell culture platforms should review the patent claims to assess potential licensing needs or design-around implications.
What to do next
- Monitor for updates
Archived snapshot
Apr 7, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Integrated system for 3D tissue culture
Grant US12595449B2 Kind: B2 Apr 07, 2026
Assignee
VALO HEALTH, INC.
Inventors
Roozbeh Aschar-Sobbi, Maw-Lin Kuo, Roger Stenerson, Winston Sun, Dickshitha Thyagharajon, Ya Kevin Thao, Chris Todd, Brian Wilfley
Abstract
Embodiments described herein relate generally to devices, apparatuses, and systems with embedded electrodes for growing, maintaining, and/or using 3D tissues in vitro. The devices, apparatuses, and systems described herein can provide scalable, automated tissue stimulation.
CPC Classifications
C12M 21/08 C12M 1/3446 C12M 23/12 C12M 35/02 C12M 41/48 C12M 41/40 C12N 2513/00 C12N 2533/40
Filing Date
2021-02-03
Application No.
17798048
Claims
13
Named provisions
Related changes
Get daily alerts for USPTO Patent Grants - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.